目的:觀察白芍總苷(TGP)聯合甲氨喋呤(MTX)和柳氮磺吡啶(SASP)治療強直性脊柱炎(AS)療效和安全性。方法:58例符合強直性脊柱炎標準的患者隨機納入2組:治療組:29例,口服白芍總苷+甲氨喋呤+柳氮磺吡啶;對照組:29例,口服甲氨喋呤+柳氮磺吡啶,兩組療程均為3月。結果:經3月治療,兩組間Schober實驗、胸廓擴張度、晨僵持續時間、血沉(ESR)及C反應蛋白(CRP)等5項指標較治療前均顯著降低(P lt;0.01),但治療組上述指標改善值優于對照組,差異分別有顯著意義(P lt;0.05)或極顯著意義(P lt;0.01);治療組不良反應發生率明顯少于對照組(P lt;0.05)。結論:白芍總苷聯合甲氨喋呤和柳氮磺吡啶是治療強直性脊柱炎安全有效方法。
Citation: XIONG Jinhe,TANG Xuemei. Clinical Observation of Total Glycosides of Wite Paeony Combined with Methotrexate and Sulfasalazine on the Treatment of Ankylosing Spondylitis. West China Medical Journal, 2009, 24(4): 892-894. doi: Copy
Copyright ? the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved

